Fund Holdings — Finepoint Capital LP

Total Portfolio Value
$289.11M
Total Bought
$71.05M
Total Sold
$33.04M
Net Transaction
+$38.01M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
CYTOKINETICS INC(CYTK)431,693431,693012,71836,04212.47%+23,324
HOME PLATE ACQUISITION CORP690,000331,416-358,584020,0146.92%+20,014
LIBERTY BROADBAND CORP(LBRDA)0184,460+184,460014,8665.14%+14,866
ACADIA PHARMACEUTICALS INC556,553769,653+213,10011,59924,0988.34%+12,499
ARVINAS INC(ARVN)504,700504,70009,91220,7737.19%+10,861
SPRINGWORKS THERAPEUTICS INC556,928556,928012,87620,3287.03%+7,452
RELAY THERAPEUTICS INC(RLAY)870,8701,317,870+447,0007,32414,5105.02%+7,186
MORPHIC HOLDING INC325,356496,856+171,5007,45414,3494.96%+6,895
REVOLUTION MEDICINES INC(RVMD)427,000617,100+190,10011,81917,6986.12%+5,879
ASCENDIS PHARMA A/S(ASND)163,772163,772015,33620,6277.13%+5,291
TRAVERE THERAPEUTICS INC(TVTX)895,8211,435,321+539,5008,00912,9044.46%+4,895
SOLID BIOSCIENCES INC961,251961,25102,4225,9022.04%+3,480
AMICUS THERAPEUTICS INC
COM
1,489,0251,489,025018,10721,1297.31%+3,023
GALAPAGOS NV(LKFT)458,659458,659015,84718,6446.45%+2,798
CONCORD ACQUISITION CORP II(CNDA)408,333408,333043530.02%+10
MARBLEGATE ACQUISITION CORP735,000735,000014220.01%+9
CHURCHILL CAPITAL CORP V612,0000-612,00000—0
YS BIOPHARMA CO LTD489,999489,999017130.00%-4
SWIFTMERGE ACQUISITION CORP490,000490,000035200.01%-15
ROSS ACQUISITION CORP II439,666439,666049250.01%-24
COMPASS DIGITAL ACQUISITION CORP459,906459,9060101220.01%-79
CHURCHILL CAPITAL CORP VI540,0000-540,000860—-86
CHURCHILL CAPITAL CORP VII548,000548,0000169710.02%-97
CALIDI BIOTHERAPEUTICS INC655,200655,2000144330.01%-111
CALIDI BIOTHERAPEUTICS INC125,000125,00004161890.07%-227
BRIDGETOWN HOLDINGS LTD895,0000-895,0003040—-304
ARES ACQUISITION CORP504,7060-504,7063340—-334
SAREPTA THERAPEUTICS INC(SRPT)145,357145,357017,62014,0174.85%-3,603
PROTHENA CORP PLC
SHS
349,300349,300016,85412,6944.39%-4,160
CEREVEL THERAPEUTICS HLDNG I563,3450-563,34512,2980—-12,298
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)331,416895,000+563,58418,891630.02%-18,828
Page 1 of 1
Finepoint Capital LP — 13F Holdings — Q4 2023 | TickerTrail